Dental Sales Flyer - September 2012 - (Page 38)

Help Your Patients Save Money & Take Control of Cold Sores. Denavir® (penciclovir cream, 1%) is indicated for the treatment of recurrent herpes labialis (cold sores) in adults and children 12 years of age and older. When you prescribe Denavir (penciclovir cream, 1%) for cold sores, patients pay no more than $15 with a money-saving coupon (subject to eligibility restrictions and limitations).† Plus, with Denavir available in a 5-gram tube, there’s no waiting for another prescription at the next outbreak. Reduction in the duration of pain associated with the lesion.1 Denavir reduces the duration of the lesion, providing relief from the pain associated with it.1 Efficacy at your patient’s fingertip.1 Patients apply steroid-free Denavir directly to the cold sore,1 providing relief from the discomfort, dryness and cracking.2 The same trusted MOA as oral antivirals.1,3,4 Denavir is an effective, topical cream, antiviral medication that is not systemically absorbed.*1 Dosing every 2 hours during waking hours for a period of 4 days.1 *The systemic absorption of penciclovir following topical administration has not been evaluated in patients less than 18 years of age.1 New American Therapeutics, Inc. supports dentists and patients with educational materials and coupons (Subject to eligibility restrictions and limitations. Please see full restrictions and limitations).† Download both for free at Denavir.com or call 1-888-DENAVIR (1-888-336-2847). Denavir® (penciclovir cream, 1%) is indicated for the treatment of recurrent herpes labialis (cold sores) in adults and children 12 years of age and older. IMPORTANT SAFETY INFORMATION Denavir should only be used on herpes labialis on the lips or face. Application to mucous membranes is not recommended. Denavir should not be used in patients with known hypersensitivity to the product or any of its ingredients. There are no adequate and well-controlled Denavir studies in pregnant women; therefore, Denavir should be used during pregnancy only if clearly needed. There is no information on whether Denavir is excreted in human milk after topical administration; a decision whether to discontinue Denavir should take into account the importance of the drug to the mother. The effect of Denavir has not been established in immunocompromised patients. Denavir does not cure cold sores. In clinical studies, the most common adverse reaction with Denavir was headache, which occurred in 5.3% of patients who received Denavir and 5.8% of patients who received placebo. Other adverse reactions with Denavir occurred in less than 2% of patients and included application site reaction, decreased sensitivity to touch/local anesthesia, taste perversion, and rash. Other reported adverse reactions have included swelling of the mouth or throat, pain, alterations in sense of smell, abnormal touch sensation, itching, skin discoloration, and hives. Denavir is available by prescription only. Please see the Full Prescribing Information on the back. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. † If a patient’s co-pay or pharmacy bill exceeds $15, they can present the certiﬁcate to the pharmacist for an instant rebate of up to a maximum of $45 for each Denavir prescription. If their total out of pocket pharmacy bill exceeds $60 for any single Denavir prescription, they will be responsible for the additional balance. Not valid with any other offer. Subject to eligibility restrictions and limitations. This offer is not valid for prescriptions reimbursed in whole or part by Medicaid, Medicare, or any other federal or state program (including any prescription drug programs). This offer is not valid in Massachusetts except for cash-paying patients, or where otherwise prohibited by law. References 1. Denavir (penciclovir cream, 1%) Prescribing Information. Cranford, NJ: New American Therapeutics, Inc. December, 2010. 2. Boon R, Goodman JJ, Martinez J, et al; for the Penciclovir Cream Herpes Labialis Study Group. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Clin Ther. 2000;22:76-90. 3. Valtrex (valacyclovir hydrochloride) Prescribing Information. Research Triangle Park, NC: GlaxoSmithKline September, 2008. 4. Famvir (famciclovir) Prescribing Information. East Hanover, NJ: Novartis Pharmaceuticals Corporation. December, 2009. Progress through practical innovation natxcorp.com 4 Becker Farm Road, Roseland, NJ 07068 ©2012 New American Therapeutics, Inc. 12/2011 DEN-0076 (penciclovir cream,1%) 38 To Order Call: 1-800-372-4346 8am-9pm, ET Or Fax at: 1-800-732-7023 24 Hours http://www.fda.gov/medwatch http://www.natxcorp.com

Table of Contents for the Digital Edition of Dental Sales Flyer - September 2012

Dental Sales Flyer - September 2012
Table of Contents
3M ESPE
ACE Surgical
Anesthetics
Argen
BeeSure
Brain Pad
CAD/CAM
Camlog
CAO
Cements & Liners
Colgate
Coltene
Cosmetic Dentistry
Cover Specials
Crosstex
Crown & Bridge
Denavir
Dentsply Caulk
Dentsply Midwest
Dentsply Professional
Disposables
DMG
Endodontics
Equipment
Evacuation
GC America
Gloves
Handpieces
HealthCare Apparel
Henry Schein Brand
Heraeus
HuFriedy
Impression Material
Infection Control
Instruments
J. Morita
Johnson & Johnson
KaVo
Kerr
Medelita
Medicom
Miltex
MiniMark
MTA
New Products
NSK
Office Supplies
OneFill
Oral DNA
Oral Health America
Oral-B
Ortho Organizers
Pentron Ceramics
Pins & Posts
Practice Marketing
Preventives
Privileges
ProRepair
SciCan
SDI
Septodont
Sleep Complete
Small Equipment
Spotlight Products
Sunstar
Super Specials
Supermax
Surgical Products
Temrex
Think Pink
Tidi Products
Totalcare
Vista
Voco
Whitening
X-ray & Accessories
Corporate Brand Onsert
Premier Onsert
Think Pink

Dental Sales Flyer - September 2012